The hub contains original content from five conferences including ACC’s 2022 and 2023 Annual Scientific Session, with additional conferences to be added in the future
News | Cardiovascular Education
Evermed, ACC Launch ACC Anywhere, the 'Netflix of Cardiology'

March 30, 2023 — Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new ...

Home March 30, 2023
Home
The breakthrough findings solve a known problem for scientists working on cellular reprogramming, one of the most promising areas of regenerative medicine
News | Heart Failure
Heart Attack Study Could Change the Game in Regenerative Medicine

March 30, 2023 — Sanford Burnham Prebys researchers have identified a group of proteins that could be the secret to ...

Home March 30, 2023
Home
Growth-focused leader will help bring the company’s AI-powered cardiovascular technology to market 
News | Cardiovascular Business
Andrew Miller Joins Elucid as Chief Technology Officer

March 29, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

Home March 29, 2023
Home
More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men
News | Womens Cardiovascular Health
Women are More Likely to Experience Long-term Anxiety After Cardiac Arrest than Men

March 29, 2023 — More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men ...

Home March 29, 2023
Home
A joint team of researchers from POSTECH and Georgia Institute of Technology successfully created an engineered heart via 3D printing technology that allows for early monitoring of drug-induced cardiotoxicity
News | Medical 3-D Printing
In Vitro 3D Engineered Heart Tissue that Monitors Drug-induced Cardiotoxicity

March 29, 2023 — Cardiotoxicity is a clinical condition that arises from using pharmaceutical agents such as antibiotics ...

Home March 29, 2023
Home
News | Cardiovascular Clinical Studies
Multi-Ethnic Study of Atherosclerosis Sheds Light on Sleep Irregularity and Cardiovascular Disease

March 29, 2023 — Irregular sleep patterns may play a role in the pathophysiologic development of cardiovascular disease ...

Home March 29, 2023
Home
People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart disease during their lifetime, according to a new study
News | Heart Failure
Low-dose Radiation Linked to Heart Disease

March 28, 2023 — People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart ...

Home March 28, 2023
Home
Royal Philips has announced the debut of a comprehensive approach to telehealth with Philips Virtual Care Management. The solution’s condition-specific protocols now include heart disease and hypertension, as well as other chronic conditions. Photo credit: Getty Images
News | Remote Monitoring
Philips Debuts Remote Patient Management Solution

March 28, 2023 — Royal Philips has announced its debut of Philips Virtual Care Management, a comprehensive approach to ...

Home March 28, 2023
Home
ECGenius System and CARDIALYTICS Suite recognized as critical to the evolution of electrophysiology
News | EP Lab
CathVision Announces Key Milestones in Advance of ECGenius Commercial Launch

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
The Society for Cardiovascular Angiography and Interventions (SCAI) and the Heart Rhythm Society (HRS) released an updated expert consensus statement on transcatheter left atrial appendage closure (LAAC)
News | Left Atrial Appendage (LAA) Occluders
SCAI and HRS Release Expert Consensus on Transcatheter Left Atrial Appendage Closure

March 28, 2023 — The Society for Cardiovascular Angiography and Interventions (SCAI) and the Heart Rhythm Society (HRS) ...

Home March 28, 2023
Home
PH-HFpEF affects more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030
News | Cardiovascular Clinical Studies
Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

March 27, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and ...

Home March 27, 2023
Home
Extends HeartBeam’s reach with FDA-cleared Halo+ atrial fibrillation detection system and physician-prescribed integrated patient care platform
News | ECG
HeartBeam Announces Acquisition of LIVMOR Assets Extending Reach with FDA-cleared Halo+ Atrial Fibrillation Detection System

March 27, 2023 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ...

Home March 27, 2023
Home
An analysis based on the EAST – AFNET 4 trial
News | Atrial Fibrillation
Is Early Rhythm Control in Atrial Fibrillation Care Cost-effective?

March 27, 2023 — Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces ...

Home March 27, 2023
Home
The recalled product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
News | Antiplatelet and Anticoagulation Therapies
Ascend Laboratories Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules Due to the Detection of NDMA Impurity

March 24, 2023 — According to the U.S. Food and Drug Administration (FDA), Ascend Laboratories LLC is voluntarily ...

Home March 24, 2023
Home
CardioMEMS is a tiny implantable sensor that can remotely flag early warning signs of worsening heart failure
News | Heart Failure
New Data Show Remote Monitoring Technology Like Abbott’s Cardiomems Helps Improve Survival in Heart Failure Patients

March 24, 2023 — Abbott announced new data that found monitoring patients remotely with hemodynamic pressure sensing ...

Home March 24, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now